Response to subdermal implantation of textured microimplants in humans

In lieu of the problems involved with the use of foreign substances such as ivory, paraffin, liquid silicone, and collagen, a new subcutaneous injectable device has been developed. This material—Bioplastique—has been developed in an attempt to overcome the shortcomings of previous augmentation materials, most notably absorption, migration, and immunologic rejection. This article presents a longitudinal study of the use of this new microimplant.